Additional clues may facilitate the development of new strategies for the successful treatment of many obesity- related malignancies, such as by increasing APN serum concentration or antagonizing its receptors, and/or by targeting APN signaling pathways. Here, ANPEP is linked to obesity due to melanocortin 4 receptor deficiency.